Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by JeremyBauherkon Dec 31, 2018 11:58am
99 Views
Post# 29172152

RE:RE:RE:RE:RE:Reverse Split

RE:RE:RE:RE:RE:Reverse SplitYou are exactly right MjMilo1369. In fact, I am very critical of reverse stock splits when it involves penny stock companies, as most, if not all, never seem to have a veritable backup plan to sustain the post R/S pps. As a case in point, I often fall back on another penny stock R/S fiasco undertaken by FuelCell Energy (FCEL) in Dec. 2015. Months before, I voted against the R/S in a proxy vote.. Naturally, it did pass. I asked mgmt why they thought it was necessary and they replied what seemed like the most nonsensical thing. They explained that institutions would be more eager to buy FCEL because they would be liable for less fees associated to the lesser shares they could now own. Their words, not mine. And so, I bailed. The pps went from 80 cents to 9.80 in that R/S ( 1 for 12). 3 years later, you will find FCEL trading at an all time historic lows of 47 cents or 3.9 cents pre R/S. So much for institutional interest in FCEL. Not to be undone, though, FCEL was sure to add hundreds of millions of shares to the hugely reduced outstanding share count. From 30M in 2015 after the R/S to 300M today. And all of that was done at the expense of shareholders who bought into those new post R/S prices. Do not doubt for a moment that FCEL is not already considering another one. As for HUGE and its very own agenda that involves becoming an overnight large cap via a R/S? I want no part of it. The whole premise behind investing in penny stocks does not include those that pretend they have become one with a R/S. If I want to buy large caps, I know how to find long standing credible ones. For now, sadly, my approach to trading HUGE shall remain that of a day trader's.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse